Amyloid Pathologies Modulate the Associations of Minimal Depressive Symptoms With Cognitive Impairments in Older Adults Without Dementia

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2021
Source ID
10.1016/j.biopsych.2020.07.004

Entities

People

  • Jie-qiong Li
  • Jin-Tai Yu
  • Lan Tan
  • Qiang Dong
  • Wei Feng
  • Wei Xu
  • Xue-ning Shen
  • Ya-hui Ma
  • Yan-lin Bi

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • Fudan University
  • GE HealthCare
  • Hoffmann-La Roche
  • IXICO
  • Johnson & Johnson Pharmaceutical Research and Development
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • National Natural Science Foundation of China
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense